EVER Neuro Pharma GmbH

Autriche


Commandez votre montre hebdomadaire EVER Neuro Pharma GmbH
Quantité totale PI 49
Rang # Quantité totale PI 28 768
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 052
Parent Ever Pharma Holding Ges.m.b.h
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

3 4
4 3
4 24
5
 
Dernier brevet 2023 - Apomorphine prodrugs and uses th...
Premier brevet 2004 - Neuroprotective dietary supplement
Dernière marque 2021 - DATA-MINE
Première marque 1953 - CEREBROLYSIN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Medical devices and instruments for the treatment of Parkinson's disease.
2023 Invention Apomorphine prodrugs and uses thereof. The present invention relates to a compound of formula (I)...
2021 P/S downloadable software for operating and retrieving information from infusion pumps software as a ...
P/S Software for infusion pumps. Software as a service [saas] with software for infusion pumps.
Invention Method for producing a mammalian brain protein hydrolysate. A method for producing a mammalian b...
Invention Method for producing a mammalian brain protein hydrolysate. Disclosed is a method for producing a...
P/S Pharmaceuticals; medical and veterinary preparations; sanitary preparations for medical purposes...
P/S Pharmaceutical preparations for the treatment of Parkinson's disease. Medical apparatus and inst...
2018 Invention Use of cerebrolysin. Disclosed is cerebrolysin for use in reducing mortality in CADASIL (cerebra...
Invention Use of cerebrolysin. Disclosed is cerebrolysin for use in reducing mortality in CADASIL (cerebral...
2016 Invention Aqueous composition of apomorphine for subcutaneous administration. The present invention relate...
Invention Aqueous composition of apomorphine for subcutaneous administration. The present invention relates...
P/S Medical devices (apparatus and instruments), namely, syringes for medical purposes, syringes for ...
P/S Medical devices (apparatus and instruments) for treatment of Parkinson's disease.
2014 P/S Pharmaceutical preparations used for the treatment of central nervous system diseases and neurode...
P/S Pharmaceutical and veterinary preparations; hygienic preparations adapted for medical use; diete...
P/S Pharmaceutical preparations for treatment of Parkinson's disease. Medical devices for treatment ...
P/S Pharmaceutical and veterinary preparations.
2013 Invention Oromucosal apomorphine compositions. An oromucosal solution comprising about 1-8% (w/v) apomorph...
2011 P/S Pharmaceutical preparations for cerebral brainorganically caused metabolic derangements; pharmace...
2009 P/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic...
2007 Invention Neuroprotective compounds and uses thereof. The present invention relates to a neuroprotective co...
2006 P/S Pharmaceutical and veterinary products; sanitary products for medical purposes; dietetic substan...
P/S Dietetic preparations and food supplements for medical use.
P/S [ Pharmaceutical and veterinary preparations used for treatment of cancer, central nervous system...
P/S Dietetic substances and food supplements adapted for medical use.
2005 Invention Neuroprotective dietary supplement. The invention relates to a novel dietary supplement mixture h...
P/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ...
1996 P/S Medicines; organ preparations for stimulating brain metabolism.
1994 P/S pharmaceutical preparations for the treatment of cerebral diseases
1993 P/S Pharmaceutical preparations for use in the treatment of cerebral diseases.
1992 P/S Produits pharmaceutiques.
1991 P/S Produits pharmaceutiques, vétérinaires et hygiéniques; substances diététiques destinées à la méd...
1953 P/S Medicines.